Clinical Trials Insurance

All Clinical Research Sites (CRSs), where required by country regulation or law, must have secured clinical trials insurance for every new and ongoing clinical trial sponsored by DAIDS to ensure compliance with the European Medicines Agency Committee for Proprietary Medicinal Products, Art 5.8 CPMP/ICH/135/95 and the Integrated Addendum to ICH (E6) (R1): Guideline for Good Clinical Practice E6 (R2) regarding Investigator/Institution insurance against trial related claims.

Currently, the U.S. does not have a law or regulation requiring the purchase of Clinical Trials Insurance.

List of Countries Requiring Clinical Trials Insurance for DAIDS funded CRSs*
CRS Continent CRS Country
S. America Argentina
N. America Canada (depends on province)
Asia India
Asia Indonesia
Africa Kenya
Africa Malawi
N. America Mexico
S. America Peru
Asia Philippines
Africa South Africa
Africa Swaziland
Europe Switzerland
Africa Tanzania
Africa Uganda
Europe Ukraine
Asia Viet Nam
Africa Zambia
Africa Zimbabwe

*Information is current as of 08/19/2021

Content last reviewed on